Can herpes simplex virus type 2 suppression slow HIV disease progression: a study protocol for the VALacyclovir In Delaying Antiretroviral Treatment Entry (VALIDATE) trial

by Cahn Pedro, Grinsztejn Beatriz, Kaul Rupert, Raboud Janet M, Tan Darrell HS, Walmsley Sharon L
Published 2010-11-01

Regional differences in rates of HIV-1 viral load monitoring in Canada: Insights and implications for antiretroviral care in high income countries

by Cooper Curtis, Klein Marina B, Bayoumi Ahmed M, Su DeSheng, Loutfy Mona R, Raboud Janet M, Machouf Nima, Rourke Sean, Walmsley Sharon, Rachlis Anita, Harrigan P Richard, Smieja Marek, Tsoukas Christos, Montaner Julio SG, Hogg Robert S
Published 2010-02-01

Recombinant HBsAg Vaccine in Persons with HIV: Is Seroconversion Sufficient for Long-term Protection?

by Powis, Jeff
Published 2010

Clinical Implications of HIV-1, HSV-2 Co-infection and Opportunities for Intervention

by Tan, Darrell Hoi-San
Published 2012

Recombinant HBsAg Vaccine in Persons with HIV: Is Seroconversion Sufficient for Long-term Protection?

by Powis, Jeff
Published 2010

Clinical Implications of HIV-1, HSV-2 Co-infection and Opportunities for Intervention

by Tan, Darrell Hoi-San
Published 2012